Pseudallescheria boydii keratitis

J Pediatr Ophthalmol Strabismus. 2006 Mar-Apr;43(2):114-5. doi: 10.3928/0191-3913-20060301-14.

Abstract

We describe a patient with Pseudallescheria boydii keratitis. The treatment of mycotic keratitis remains difficult. This case demonstrates that identification and susceptibility testing should be rapidly performed. In cases of indolent keratitis, the possibility of fungal infection should be kept in mind.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Cyclopentolate / therapeutic use
  • Drug Therapy, Combination
  • Eye Infections, Fungal / diagnosis
  • Eye Infections, Fungal / drug therapy
  • Eye Infections, Fungal / microbiology*
  • Glucocorticoids / therapeutic use
  • Humans
  • Keratitis / diagnosis
  • Keratitis / drug therapy
  • Keratitis / microbiology*
  • Male
  • Mycetoma / diagnosis
  • Mycetoma / drug therapy
  • Mycetoma / microbiology*
  • Natamycin / therapeutic use
  • Prednisolone / analogs & derivatives
  • Prednisolone / therapeutic use
  • Pseudallescheria / isolation & purification*

Substances

  • Antifungal Agents
  • Glucocorticoids
  • Amphotericin B
  • prednisolone acetate
  • Natamycin
  • Prednisolone
  • Cyclopentolate